Products

PGxAI
PGxAI
Clinical Decision Support & Reference

See all 1 product →

About PGxAI

PGxAI is a healthcare AI company at the forefront of precision medicine, specifically focusing on pharmacogenomics. The company develops an artificial intelligence-powered platform designed to optimize patient outcomes by personalizing drug selection, dosing, and interaction management based on an individual’s unique genetic makeup. Their platform utilizes advanced AI and data analytics to support clinical decision-making, accelerate drug development, and improve success rates through targeted patient stratification and real-time analytics.

For physicians, PGxAI offers a configurable clinician-facing platform that provides evidence-linked clinical decision support. It helps licensed healthcare professionals review relevant medication-safety and pharmacogenomic information in a structured workflow. This includes drug-drug interaction review, identification of contraindications and precautions, and retrieval of pharmacogenomic guidance when interpreted results are available. The platform integrates with existing EHR and hospital workflows, delivering real-time clinical decision support and translating complex genetic data into clear, actionable clinical guidance. This aims to empower physicians to evaluate a wider range of treatment options, reduce the likelihood of serious adverse reactions, and move towards precision prescribing at scale.

Focus Areas

pharmacogenomics clinical decision support precision medicine AI in healthcare drug-drug interaction review contraindication review pharmacogenomic guidance retrieval real-world evidence

Business Intelligence

TechnologyAI-powered multiomics platform, cloud-native, HPC technology, VectorSearch, GenAI, InterSystems IRIS for Health, InterSystems HealthShare, InterSystems TrakCare

What Physicians Need to Know

Pharmacogenomics & Precision Medicine
PGxAI specializes in AI-driven pharmacogenomics, personalizing drug selection, dosing, and interaction management based on a patient's unique genetic makeup. Their reports cover over 730 drugs and 40 genes, offering significantly broader coverage than many competitors. They aim to reduce adverse drug reactions, which account for substantial healthcare costs.
Clinical Decision Support
PGxAI provides evidence-linked clinical decision support for healthcare professionals, surfacing drug-drug interactions, contraindications, and pharmacogenomic guidance from FDA-required labeling and established sources. Their AI-driven reports translate complex genetic data into clear clinical guidance, empowering physicians to make proactive adjustments to dosage or consider safer alternatives.
AI in Healthcare & Real-World Evidence
PGxAI leverages advanced AI models, including generative AI (GenAI) and real-world evidence (RWE), to analyze genetic variations and predict drug efficacy, dosage, and adverse event risk. Their platform continuously learns from real-world outcomes to provide continuously improving, population-aware decision support.
Drug-Drug Interaction & Contraindication Review
The platform retrieves and displays relevant drug-drug interaction findings from FDA-required labeling and identifies contraindications and precautions against structured clinical information.
Pharmacogenomic Guidance Retrieval
PGxAI offers automated retrieval of pharmacogenomic guidance, transforming personalized prescribing from a lengthy manual process into a rapid, clinically actionable reality.
Physician Tip

For physicians, PGxAI offers a powerful tool to move beyond 'trial-and-error' prescribing by providing personalized, genetic-based insights into drug efficacy and safety. This can lead to proactive dosage adjustments, consideration of safer alternatives, and a reduction in adverse drug reactions. The platform integrates seamlessly into existing EHR and hospital workflows, delivering real-time clinical decision support without disrupting care processes. This allows you to focus on patient care with a wider range of options and reduced likelihood of serious adverse events. PGxAI's reports are designed to be 'plug-and-play' for genomic labs, offering new revenue streams while delivering measurable benefits for patients.

PGxAI's technology is built on robust partnerships with leading technology providers including NVIDIA, InterSystems, Google, and Microsoft. They integrate with InterSystems' HealthShare to deliver real-time clinical decision support directly into EHR and hospital workflows. The platform is also built on InterSystems IRIS for Health and FHIR-native TrakCare standards, allowing it to ingest longitudinal data directly from EHRs, LIMS, and wearable devices. PGxAI's reports seamlessly integrate with major reporting formats from clinically actionable consumer genetic testing services, allowing for easy upload of genetic data.

Products by PGxAI

1 product in the directory

PGxAI
PGxAI
Clinical Decision Support & Reference

Videos

News, demos, and interviews about PGxAI.

Loading videos...

Videos load interactively. If none appear, search YouTube for PGxAI →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

PGxAI is an AI-powered pharmacogenomics platform that redefines precision medicine by using proprietary algorithms and real-world data to personalize drug selection, dosage, and interaction management. It leverages advanced AI models to rapidly correlate a patient's genetic profile with pharmacogenomic markers and clinical evidence, providing actionable insights for physicians.
PGxAI offers a configurable platform that surfaces drug-drug interactions, contraindications, and pharmacogenomic guidance from FDA-required labeling and established sources for independent clinician review. It also provides review support and traceability, presenting cited excerpts and source links for clinicians to evaluate findings.
PGxAI's platform is designed to continuously learn from real-world evidence (RWE) to individualize drug therapy. It can incorporate validated retrospective or real-world datasets as supplementary context for defined clinical review scenarios, though these do not replace source-based review or clinician judgment.
PGxAI retrieves pharmacogenomic guidance from FDA-required labeling, CPIC guidance, DPWG guidance where applicable, and FDA pharmacogenetic association resources. The software is intended to help licensed healthcare professionals review relevant information and is not designed to perform genetic testing, interpret raw laboratory data, provide diagnoses, automate order entry, or issue treatment directives.
PGxAI offers foundational modules for drug-drug interaction review, contraindication/precaution review, and pharmacogenomic guidance retrieval when interpreted PGx results are already present. They also have a broader configurable mode that includes these foundational modules and a bounded set of RWE-enabled review modules for defined clinician review scenarios.
PGxAI has established partnerships with leading technology providers such as NVIDIA, InterSystems, Google, and Microsoft to integrate its solutions into EHR and hospital workflows. The company was founded in 2023 and is backed by VC firm ATEM Capital, with an advisory board including experts from Stanford University, Thermo Fisher, and GE Healthcare.
PGxAI integrates with existing EHR and hospital workflows, notably through partnerships with companies like InterSystems (via its HealthShare platform), to deliver real-time clinical decision support directly into these systems. This allows for immediate implementation without disrupting existing care processes.

Related Companies

Stanford University, through its online learning platform Stanford Online (online.stanford.edu), provides a wide array of educational opportunities, including those focused on Artificial Intelligence (AI) in healthcare. Stanford Online aims to extend the university’s academic excellence and breakthrough research to a global audience, offering programs taught by Stanford faculty and industry experts. These offerings range from […]

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Google Workspace provides a comprehensive suite of secure online productivity and collaboration tools designed for various organizational sizes, including businesses, enterprises, and frontline workers. For physicians and healthcare professionals, Google Workspace offers a secure environment for communication, data storage, and document management, which is crucial for maintaining patient confidentiality and operational efficiency. The platform integrates […]

Pacmed is an Amsterdam-based clinical intelligence company that develops and implements AI solutions to improve hospital care, with a particular focus on the Intensive Care Unit (ICU). The company’s core product, Pacmed Critical, is an AI platform designed to optimize ICU capacity, enhance patient outcomes, and provide data-driven insights for medical professionals. This platform integrates […]

AiZtech Labs is a pioneering deep tech company that leverages AI to transform healthcare by providing accessible and rapid screening tools. Their mission is to enhance the quality of life for one billion people by blending world-class AI research with human-centered design. The company’s flagship platform, iSelfie BioSignals, utilizes a smartphone camera to detect digital […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.